chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Erythema, Feeling cold, Pain in extremity
Clinical narrative: swelling on the arm of the vaccination; redness on the arm of the vaccination; loss of appetite; being very cold; soreness in the vaccination arm; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-May-2021 and was forwarded to Moderna on 20-May-2021.    This spontaneous case was reported by a patient and describes the occurrence of FEELING COLD (being very cold), DECREASED APPETITE (loss of appetite), PERIPHERAL SWELLING (swelling on the arm of the vaccination), ERYTHEMA (redness on the arm of the vaccination) and PAIN IN EXTREMITY (soreness in the vaccination arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 043B212A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE and VITAMINS NOS (DAILY VITAMINS) for an unknown indication.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced FEELING COLD (being very cold), PAIN IN EXTREMITY (soreness in the vaccination arm) and CHILLS (chills). On 19-May-2021, the patient experienced DECREASED APPETITE (loss of appetite). On 20-May-2021, the patient experienced PERIPHERAL SWELLING (swelling on the arm of the vaccination) and ERYTHEMA (redness on the arm of the vaccination). At the time of the report, FEELING COLD (being very cold), DECREASED APPETITE (loss of appetite), PERIPHERAL SWELLING (swelling on the arm of the vaccination), ERYTHEMA (redness on the arm of the vaccination), PAIN IN EXTREMITY (soreness in the vaccination arm) and CHILLS (chills) had not resolved.            No treatment medication was reported.  Action taken with mRNA-1273 with respect to events was not applicable.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: swelling on the arm of the vaccination; redness on the arm of the vaccination; loss of appetite; being very cold; soreness in the vaccination arm; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-May-2021 and was forwarded to Moderna on 20-May-2021.    This spontaneous case was reported by a patient and describes the occurrence of FEELING COLD (being very cold), DECREASED APPETITE (loss of appetite), PERIPHERAL SWELLING (swelling on the arm of the vaccination), ERYTHEMA (redness on the arm of the vaccination) and PAIN IN EXTREMITY (soreness in the vaccination arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 043B212A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE and VITAMINS NOS (DAILY VITAMINS) for an unknown indication.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced FEELING COLD (being very cold), PAIN IN EXTREMITY (soreness in the vaccination arm) and CHILLS (chills). On 19-May-2021, the patient experienced DECREASED APPETITE (loss of appetite). On 20-May-2021, the patient experienced PERIPHERAL SWELLING (swelling on the arm of the vaccination) and ERYTHEMA (redness on the arm of the vaccination). At the time of the report, FEELING COLD (being very cold), DECREASED APPETITE (loss of appetite), PERIPHERAL SWELLING (swelling on the arm of the vaccination), ERYTHEMA (redness on the arm of the vaccination), PAIN IN EXTREMITY (soreness in the vaccination arm) and CHILLS (chills) had not resolved.            No treatment medication was reported.  Action taken with mRNA-1273 with respect to events was not applicable.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Breast swelling, Headache, Myalgia
Clinical narrative: swelling in left breast area; soreness left breast area; swelling under her left arm pit; soreness under left arm pit; Left arm soreness; headache / headache worse; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (swelling in left breast area), BREAST PAIN (soreness left breast area), SWELLING (swelling under her left arm pit), AXILLARY PAIN (soreness under left arm pit) and MYALGIA (Left arm soreness) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, NORGESTREL (CRYSELLE) for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced BREAST SWELLING (swelling in left breast area), BREAST PAIN (soreness left breast area), SWELLING (swelling under her left arm pit), AXILLARY PAIN (soreness under left arm pit), MYALGIA (Left arm soreness) and HEADACHE (headache / headache worse). At the time of the report, BREAST SWELLING (swelling in left breast area), BREAST PAIN (soreness left breast area), SWELLING (swelling under her left arm pit), AXILLARY PAIN (soreness under left arm pit), MYALGIA (Left arm soreness) and HEADACHE (headache / headache worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: swelling in left breast area; soreness left breast area; swelling under her left arm pit; soreness under left arm pit; Left arm soreness; headache / headache worse; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (swelling in left breast area), BREAST PAIN (soreness left breast area), SWELLING (swelling under her left arm pit), AXILLARY PAIN (soreness under left arm pit) and MYALGIA (Left arm soreness) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, NORGESTREL (CRYSELLE) for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced BREAST SWELLING (swelling in left breast area), BREAST PAIN (soreness left breast area), SWELLING (swelling under her left arm pit), AXILLARY PAIN (soreness under left arm pit), MYALGIA (Left arm soreness) and HEADACHE (headache / headache worse). At the time of the report, BREAST SWELLING (swelling in left breast area), BREAST PAIN (soreness left breast area), SWELLING (swelling under her left arm pit), AXILLARY PAIN (soreness under left arm pit), MYALGIA (Left arm soreness) and HEADACHE (headache / headache worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Neck pain, Pain, Rash
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of PAIN ("it's like a shooting pain), NECK PAIN (and now it's going to my neck), RASH (rash), MYALGIA (pain on the arm / it's been a month and the arm hurts) and ARTHRALGIA (it's gone to my shoulder, it's like sore) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. Concurrent medical conditions included Asthma and Allergy. On 17-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced PAIN ("it's like a shooting pain), NECK PAIN (and now it's going to my neck), RASH (rash), MYALGIA (pain on the arm / it's been a month and the arm hurts) and ARTHRALGIA (it's gone to my shoulder, it's like sore). At the time of the report, PAIN ("it's like a shooting pain), NECK PAIN (and now it's going to my neck), RASH (rash), MYALGIA (pain on the arm / it's been a month and the arm hurts) and ARTHRALGIA (it's gone to my shoulder, it's like sore) outcome was unknown. Concomitant medication use was unknown. Treatment information was unknown
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Fatigue
Clinical narrative: anxiety; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (anxiety) and FATIGUE (fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced FATIGUE (fatigue). On 28-Apr-2021, the patient experienced ANXIETY (anxiety). On 11-May-2021, ANXIETY (anxiety) and FATIGUE (fatigue) outcome was unknown.            Concomitant medications are thyroid medication, cholesterol medication,allergy medication. No treatment medication details was reported.    This case was linked to MOD-2021-081773 (Patient Link).
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine given at 16 years of age .; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given at 16 years of age .) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included IBUPROFEN for Toothache.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given at 16 years of age .). On 19-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given at 16 years of age .) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided    Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Height, weight, ethnicity, medical history added.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Cough, Pyrexia
Clinical narrative: coughing; weakness; chills; pyrexia; This spontaneous case was reported by a health care professional and describes the occurrence of COUGH (coughing), ASTHENIA (weakness), CHILLS (chills) and PYREXIA (pyrexia) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Arrhythmia. Concurrent medical conditions included Atrial fibrillation (IRREGULAR HEART BEAT 122). Concomitant products included APIXABAN (ELIQUIS), LETROZOLE, DONEPEZIL, DILTIAZEM, DIGOXIN, CITALOPRAM and LEVOCETIRIZINE for an unknown indication.   On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced COUGH (coughing), ASTHENIA (weakness), CHILLS (chills) and PYREXIA (pyrexia). At the time of the report, COUGH (coughing), ASTHENIA (weakness), CHILLS (chills) and PYREXIA (pyrexia) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.6 (Inconclusive) Patient's body temperature of 100.6 degrees Fahrenheit..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication information was reported.
Age: 28.0
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: tiny bit of fever of 2 seconds; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (tiny bit of fever of 2 seconds) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Fatty liver.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (tiny bit of fever of 2 seconds). At the time of the report, PYREXIA (tiny bit of fever of 2 seconds) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported.   No treatment was reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Intentional product use issue, Vaccination site pain
Clinical narrative: Weakness; Normal pain in the injection site; More than 4month appart 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (More than 4month appart 2nd dose), ASTHENIA (Weakness) and VACCINATION SITE PAIN (Normal pain in the injection site) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (More than 4month appart 2nd dose). On an unknown date, the patient experienced ASTHENIA (Weakness) and VACCINATION SITE PAIN (Normal pain in the injection site). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (More than 4month appart 2nd dose), ASTHENIA (Weakness) and VACCINATION SITE PAIN (Normal pain in the injection site) outcome was unknown.            No relevant concomitant medications were reported.  No treatment details were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Pollakiuria
Clinical narrative: chest pains; urinating more; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pains) and POLLAKIURIA (urinating more) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 06-May-2021, the patient experienced CHEST PAIN (chest pains) and POLLAKIURIA (urinating more). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at a dose of 1 dosage form and CAMELLIA SINENSIS DRY LEAF (GREEN TEA NP) at a dose of 1 dosage form. At the time of the report, CHEST PAIN (chest pains) and POLLAKIURIA (urinating more) outcome was unknown.            No concomitant medications are provided. The action taken with the drug was Not applicable.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration
Clinical narrative: was diagnosed with Covid-19; first dose on 30Jan2021; second dose not received yet; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (was diagnosed with Covid-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 30Jan2021; second dose not received yet) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced COVID-19 (was diagnosed with Covid-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 30Jan2021; second dose not received yet). At the time of the report, COVID-19 (was diagnosed with Covid-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 30Jan2021; second dose not received yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: administered the Moderna covid19 vaccine to a 15year old teenager; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered the Moderna covid19 vaccine to a 15year old teenager) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered the Moderna covid19 vaccine to a 15year old teenager). On 14-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered the Moderna covid19 vaccine to a 15year old teenager) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medications were reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Rhinorrhoea, Vaccination site erythema
Clinical narrative: Felt very bad; Dripping nose; Rash is itching severely and more in the edges; Rash is pinkish in color; This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger; Headache; Was tired; RASH today it is size of a baseball; like sun burned RASH; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt very bad), RHINORRHOEA (Dripping nose), VACCINATION SITE PRURITUS (Rash is itching severely and more in the edges), VACCINATION SITE ERYTHEMA (Rash is pinkish in color) and VACCINATION SITE RASH (This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE for an unknown indication.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced FEELING ABNORMAL (Felt very bad), RHINORRHOEA (Dripping nose), VACCINATION SITE PRURITUS (Rash is itching severely and more in the edges), VACCINATION SITE ERYTHEMA (Rash is pinkish in color), VACCINATION SITE RASH (This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger), HEADACHE (Headache), FATIGUE (Was tired), VACCINATION SITE SWELLING (RASH today it is size of a baseball) and VACCINATION SITE PAIN (like sun burned RASH). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, FEELING ABNORMAL (Felt very bad), RHINORRHOEA (Dripping nose), VACCINATION SITE PRURITUS (Rash is itching severely and more in the edges), VACCINATION SITE ERYTHEMA (Rash is pinkish in color), VACCINATION SITE RASH (This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger), HEADACHE (Headache), FATIGUE (Was tired), VACCINATION SITE SWELLING (RASH today it is size of a baseball) and VACCINATION SITE PAIN (like sun burned RASH) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-245608 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Reporter's contact information added and lot number of vaccine updated from 022C219 to 022C21A.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Felt very bad; Dripping nose; Rash is itching severely and more in the edges; Rash is pinkish in color; This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger; Headache; Was tired; RASH today it is size of a baseball; like sun burned RASH; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt very bad), RHINORRHOEA (Dripping nose), VACCINATION SITE PRURITUS (Rash is itching severely and more in the edges), VACCINATION SITE ERYTHEMA (Rash is pinkish in color) and VACCINATION SITE RASH (This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE for an unknown indication.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced FEELING ABNORMAL (Felt very bad), RHINORRHOEA (Dripping nose), VACCINATION SITE PRURITUS (Rash is itching severely and more in the edges), VACCINATION SITE ERYTHEMA (Rash is pinkish in color), VACCINATION SITE RASH (This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger), HEADACHE (Headache), FATIGUE (Was tired), VACCINATION SITE SWELLING (RASH today it is size of a baseball) and VACCINATION SITE PAIN (like sun burned RASH). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, FEELING ABNORMAL (Felt very bad), RHINORRHOEA (Dripping nose), VACCINATION SITE PRURITUS (Rash is itching severely and more in the edges), VACCINATION SITE ERYTHEMA (Rash is pinkish in color), VACCINATION SITE RASH (This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger), HEADACHE (Headache), FATIGUE (Was tired), VACCINATION SITE SWELLING (RASH today it is size of a baseball) and VACCINATION SITE PAIN (like sun burned RASH) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-245608 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Reporter's contact information added and lot number of vaccine updated from 022C219 to 022C21A.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Hypoaesthesia, Hypokinesia, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: his hand was also stiff; nose bleed in the left nostril; left fingers numb/numbness/could not feel his fingers in his left hand; left hand hard to open and close; left hand had some pain; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose bleed in the left nostril), HYPOAESTHESIA (left fingers numb/numbness/could not feel his fingers in his left hand), HYPOKINESIA (left hand hard to open and close), MUSCULOSKELETAL STIFFNESS (his hand was also stiff) and PAIN IN EXTREMITY (left hand had some pain) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced HYPOAESTHESIA (left fingers numb/numbness/could not feel his fingers in his left hand), HYPOKINESIA (left hand hard to open and close) and PAIN IN EXTREMITY (left hand had some pain). On 20-May-2021, the patient experienced EPISTAXIS (nose bleed in the left nostril). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (his hand was also stiff). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Numbness and Pain, at an unspecified dose and frequency. In May 2021, EPISTAXIS (nose bleed in the left nostril) had resolved. On 20-May-2021, HYPOAESTHESIA (left fingers numb/numbness/could not feel his fingers in his left hand), HYPOKINESIA (left hand hard to open and close) and PAIN IN EXTREMITY (left hand had some pain) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (his hand was also stiff) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: covid-19 positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (covid-19 positive) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (covid-19 positive). At the time of the report, SARS-COV-2 TEST POSITIVE (covid-19 positive) outcome was unknown.            No concomitant medication provided by the reporter no treatment information reported by the reporter   This case was linked to US-MODERNATX, INC.-MOD-2021-155098 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-155098:Crosslinked case of reporter friend case
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing sensations in both ears/Aggravated ringing in ears; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing sensations in both ears/Aggravated ringing in ears) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, the patient experienced TINNITUS (Ringing sensations in both ears/Aggravated ringing in ears). At the time of the report, TINNITUS (Ringing sensations in both ears/Aggravated ringing in ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included- Blood pressure medicine No treatment reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, Skin mass
Clinical narrative: "Red itchy rash on both arms and between her thighs."; "Red raised bumps from scratching it."; "Red itchy rash on both arms and between her thighs."; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC ("Red itchy rash on both arms and between her thighs."), SKIN MASS ("Red raised bumps from scratching it.") and RASH ERYTHEMATOUS ("Red itchy rash on both arms and between her thighs.") in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-May-2021, the patient experienced RASH PRURITIC ("Red itchy rash on both arms and between her thighs."), SKIN MASS ("Red raised bumps from scratching it.") and RASH ERYTHEMATOUS ("Red itchy rash on both arms and between her thighs."). The patient was treated with CETIRIZINE HYDROCHLORIDE (CETRIZINE) at a dose of 10 mg. At the time of the report, RASH PRURITIC ("Red itchy rash on both arms and between her thighs."), SKIN MASS ("Red raised bumps from scratching it.") and RASH ERYTHEMATOUS ("Red itchy rash on both arms and between her thighs.") had not resolved.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chromaturia, Fatigue, Pain in extremity, Urine odour abnormal
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts), URINE ODOR ABNORMAL (Urine had acidic strong smell patient stated that it was unusual regarding the smell of the urine), CHROMATURIA (Dark yellow color of urine) and FATIGUE (Tired) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 008C21A) for COVID-19 vaccination. Concurrent medical conditions included Thyroid disorder NOS. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts), URINE ODOR ABNORMAL (Urine had acidic strong smell patient stated that it was unusual regarding the smell of the urine) and FATIGUE (Tired). 19-May-2021, the patient experienced CHROMATURIA (Dark yellow color of urine). At the time of the report, PAIN IN EXTREMITY (Arm hurts), URINE ODOR ABNORMAL (Urine had acidic strong smell patient stated that it was unusual regarding the smell of the urine), CHROMATURIA (Dark yellow color of urine) and FATIGUE (Tired) outcome was unknown. Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fever; Tired; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (Fever) and FATIGUE (Tired) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028120A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced PYREXIA (Fever) and FATIGUE (Tired). At the time of the report, PYREXIA (Fever) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was unknown Treatment information was unknown   This case was linked to MOD-2021-154330.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Illness, Pyrexia, Vertigo
Clinical narrative: Room was spinning after laying down; Dizzy, couldn't get up at times; Got Sick; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Room was spinning after laying down), DIZZINESS (Dizzy, couldn't get up at times), ILLNESS (Got Sick) and PYREXIA (Fever) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028LR0A and 028120A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VERTIGO (Room was spinning after laying down), DIZZINESS (Dizzy, couldn't get up at times), ILLNESS (Got Sick) and PYREXIA (Fever). At the time of the report, VERTIGO (Room was spinning after laying down), DIZZINESS (Dizzy, couldn't get up at times), ILLNESS (Got Sick) and PYREXIA (Fever) had resolved.            No concomitant medications was not reported. Treatment medications was not reported.   This case was linked to MOD-2021-154316 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pruritus, Rash
Clinical narrative: atypical shingles; rash right side of body; itching to the right side of the body; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching to the right side of the body), RASH (rash right side of body) and HERPES ZOSTER (atypical shingles) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 0C31321A) for COVID-19 vaccination.     no medical history information was reported.  Previously administered products included for Shingles: SHINGRIX in 2018. Concomitant products included LEVOTHYROXINE, ROSUVASTATIN and FLUOXETINE for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (itching to the right side of the body). On 24-Apr-2021, the patient experienced RASH (rash right side of body). On 26-Apr-2021, the patient experienced HERPES ZOSTER (atypical shingles). The patient was treated with CORTISONE (topical) at a dose of 1 dosage form cream; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) at a dose of 1 dosage form cream; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) at a dose of 1 dosage form; ACYCLOVIR [ACICLOVIR] at a dose of 1 dosage form and PREGABALIN at a dose of 1 dosage form. On 05-May-2021, RASH (rash right side of body) and HERPES ZOSTER (atypical shingles) had resolved. At the time of the report, PRURITUS (itching to the right side of the body) outcome was unknown.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. the patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Intentional product use issue
Clinical narrative: contracted COVID a week or two after the vaccination; no second dose past 42 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (contracted COVID a week or two after the vaccination) and INTENTIONAL PRODUCT USE ISSUE (no second dose past 42 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (contracted COVID a week or two after the vaccination) and INTENTIONAL PRODUCT USE ISSUE (no second dose past 42 days). At the time of the report, COVID-19 (contracted COVID a week or two after the vaccination) and INTENTIONAL PRODUCT USE ISSUE (no second dose past 42 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided  Treatment medications includes Antibody plasma    Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Heart rate increased, Myalgia, Pyrexia
Clinical narrative: fast heartbeat; dizziness; weakness; fever; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heartbeat), DIZZINESS (dizziness), ASTHENIA (weakness), MYALGIA (soreness in arm) and PYREXIA (fever) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced MYALGIA (soreness in arm). On 19-May-2021, the patient experienced HEART RATE INCREASED (fast heartbeat), DIZZINESS (dizziness), ASTHENIA (weakness) and PYREXIA (fever). At the time of the report, HEART RATE INCREASED (fast heartbeat), DIZZINESS (dizziness), ASTHENIA (weakness), MYALGIA (soreness in arm) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were mentioned. No treatment drugs were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: fast heartbeat; dizziness; weakness; fever; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heartbeat), DIZZINESS (dizziness), ASTHENIA (weakness), MYALGIA (soreness in arm) and PYREXIA (fever) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced MYALGIA (soreness in arm). On 19-May-2021, the patient experienced HEART RATE INCREASED (fast heartbeat), DIZZINESS (dizziness), ASTHENIA (weakness) and PYREXIA (fever). At the time of the report, HEART RATE INCREASED (fast heartbeat), DIZZINESS (dizziness), ASTHENIA (weakness), MYALGIA (soreness in arm) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were mentioned. No treatment drugs were reported.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered vaccine from vial that was past the 12 hour puncture time/vial had been kept cold in the fridge; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered vaccine from vial that was past the 12 hour puncture time/vial had been kept cold in the fridge) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered vaccine from vial that was past the 12 hour puncture time/vial had been kept cold in the fridge). On 20-May-2021, EXPIRED PRODUCT ADMINISTERED (administered vaccine from vial that was past the 12 hour puncture time/vial had been kept cold in the fridge) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided    This case was linked to US-MODERNATX, INC.-MOD-2021-155542, US-MODERNATX, INC.-MOD-2021-155523 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: FUP document included: Updated gender, vaccine route of administration and anatomical location .; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-155542: US-MODERNATX, INC.-MOD-2021-155523:
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Myalgia, Pyrexia
Clinical narrative: hot forehead; Pain at injection site; chills; muscle pain; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot forehead), VACCINATION SITE PAIN (Pain at injection site), CHILLS (chills), MYALGIA (muscle pain) and FATIGUE (Fatigue) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (hot forehead), VACCINATION SITE PAIN (Pain at injection site), CHILLS (chills), MYALGIA (muscle pain), FATIGUE (Fatigue) and PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FEELING HOT (hot forehead), VACCINATION SITE PAIN (Pain at injection site), CHILLS (chills), MYALGIA (muscle pain), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown.            Concomitant product use not provided.   Reporter did not allow further contact
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: hot forehead; Pain at injection site; chills; muscle pain; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot forehead), VACCINATION SITE PAIN (Pain at injection site), CHILLS (chills), MYALGIA (muscle pain) and FATIGUE (Fatigue) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (hot forehead), VACCINATION SITE PAIN (Pain at injection site), CHILLS (chills), MYALGIA (muscle pain), FATIGUE (Fatigue) and PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FEELING HOT (hot forehead), VACCINATION SITE PAIN (Pain at injection site), CHILLS (chills), MYALGIA (muscle pain), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown.            Concomitant product use not provided.   Reporter did not allow further contact
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Vaccination site rash
Clinical narrative: Doesn't feel good; Tired; Rash on the arm at the injection site; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Doesn't feel good), VACCINATION SITE RASH (Rash on the arm at the injection site), CHILLS (Chills) and FATIGUE (Tired) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 19-May-2021, the patient experienced VACCINATION SITE RASH (Rash on the arm at the injection site) and CHILLS (Chills). On an unknown date, the patient experienced MALAISE (Doesn't feel good) and FATIGUE (Tired). At the time of the report, MALAISE (Doesn't feel good), VACCINATION SITE RASH (Rash on the arm at the injection site), CHILLS (Chills) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pain in extremity, Peripheral swelling
Clinical narrative: Fatigue; Headache; body aches; swelling and pain in the arm; sore feet,sore hands and pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling and pain in the arm), PAIN IN EXTREMITY (sore feet,sore hands and pain in the arm), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (body aches) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced PERIPHERAL SWELLING (swelling and pain in the arm), PAIN IN EXTREMITY (sore feet,sore hands and pain in the arm), HEADACHE (Headache) and MYALGIA (body aches). On 20-May-2021, the patient experienced FATIGUE (Fatigue). The patient was treated with IBUPROFEN ongoing since an unknown date for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (swelling and pain in the arm), PAIN IN EXTREMITY (sore feet,sore hands and pain in the arm), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (body aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-155192 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up received on 01-JUL-2021.Patient updated event outcome from unknown to recovered.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-155192: